SOPHiA GENETICS SA (SOPH) Misses Q2 EPS by 7c ; Offers Guidance

SOPHiA GENETICS SA (NASDAQ: SOPH) reported Q2 EPS of ($0.30), $0.07 worse than the analyst estimate of ($0.23). Revenue for the quarter came in at $23.3 million versus the consensus estimate of $21.62 million.

Outlook:-

Full year revenue between $94 million and $96 million vs consensus $93.38 million.

For earnings history and earnings-related data on SOPHiA GENETICS SA (SOPH) click here.

You May Also Be Interested In

• Methode Electronics (MEI) Tops Q1 EPS by 2c; offers guidance
• Broadcom (AVGO) Tops Q3 EPS by 11c, Offers Guidance
• PVH Corp. (PVH) Tops Q2 EPS by 62c, Beats on Revenue; Offers FY27 EPS Guidance